Neurology clinical trials recruiting in Illinois

101 recruiting neurology trials match in Illinois. Showing 20.

• A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)Recruiting

  N/A · TG Therapeutics, Inc. · Chicago, Illinois

• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic SeizuresRecruiting

  Phase 3 · Xenon Pharmaceuticals Inc. · Springfield, Illinois

• Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)Recruiting

  Phase 3 · AbbVie · Chicago, Illinois

• Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's DiseaseRecruiting

  Phase 3 · CereMark Pharma, LLC · Evanston, Illinois

• Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric SubjectsRecruiting

  Phase 3 · Pfizer · Hawthorne, California

• TSC Biosample Repository and Natural History DatabaseRecruiting

  N/A · National Tuberous Sclerosis Association · Chicago, Illinois

• Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.Recruiting

  Phase 3 · Novartis Pharmaceuticals · Chicago, Illinois

• Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)Recruiting

  N/A · Alzheimer's Disease and Related Disorders Association, Inc · Chicago, Illinois

• A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet SyndromeRecruiting

  Phase 3 · Stoke Therapeutics, Inc · Beijing

• Communication Bridge 3 StudyRecruiting

  Phase 2 · University of Chicago · Chicago, Illinois

• Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut SyndromeRecruiting

  N/A · Ann & Robert H Lurie Children's Hospital of Chicago · Chicago, Illinois

• Use of CereGate Therapy for Freezing of Gait in PDRecruiting

  N/A · CereGate Inc. · Chicago, Illinois

• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)Recruiting

  Phase 3 · Xenon Pharmaceuticals Inc. · Springfield, Illinois

• Ublituximab (Briumvi) for Early Forms of Relapsing Multiple SclerosisRecruiting

  Phase 4 · Northwestern University · Chicago, Illinois

• Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS RegistryRecruiting

  N/A · Boston Scientific Corporation · Chicago, Illinois

• A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)Recruiting

  Phase 1 / Phase 2 · Neurona Therapeutics · Chicago, Illinois

• Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson DiseaseRecruiting

  Phase 2 · University of Illinois at Urbana-Champaign · Champaign, Illinois

• Randomized Study in Children and Adolescents With Migraine: Acute TreatmentRecruiting

  Phase 3 · Pfizer · Chicago, Illinois

• A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)Recruiting

  Phase 3 · Merck Sharp & Dohme LLC · Chicago, Illinois

• A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's DiseaseRecruiting

  N/A · InSightec · Chicago, Illinois

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.